HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.

Abstract
Cytomegalovirus (CMV)-specific hyperimmunoglobulin (CMV-HIG) is used to treat and prevent CMV infection in immunocompromised patients, and anti-CD20 monoclonal antibody is successfully used in the treatment for post-transplant lymphoproliferative disease caused by Epstein-Barr virus (EBV). Two immunological approaches have been suggested to further improve the control of viral reproduction in patients with active disease: first, the use of monoclonal antibodies with specificity against viral epitopes and second, coadministration of cells with the capacity to promote antibody-dependent cell-mediated cytotoxicity. Here, we have evaluated the effectiveness of these strategies in vitro (alone and in combination) with neutralization and cytotoxicity assays. Our results indicate that monoclonal antibodies (in particular SM5-1) can be as effective as CMV-HIG in neutralizing-cell-free CMV. Moreover, our data indicate that antibody-mediated elimination (either by moAb or by HIG) of EBV-infected cells can be significantly enhanced by NK cells. Using human NK cells that have been purified, cultured and expanded under GMP conditions, we were able to demonstrate that the combination of NK cells and antibodies could represent a feasible and highly effective clinical approach to achieve control of EBV infections. Especially in leukopenic patients with low numbers of ADCC-promoting cells, the combination of adoptively transferred NK cells and antiviral antibodies offers a promising strategy that should be tested in clinical trials.
AuthorsK Frenzel, J Lehmann, D H Krüger, L Martin-Parras, L Uharek, J Hofmann
JournalMedical microbiology and immunology (Med Microbiol Immunol) Vol. 203 Issue 2 Pg. 115-23 (Apr 2014) ISSN: 1432-1831 [Electronic] Germany
PMID24337366 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Antigens, Viral
  • Immunoglobulins
Topics
  • Antibodies, Monoclonal (immunology)
  • Antibodies, Viral (immunology)
  • Antigens, Viral (immunology)
  • Cells, Cultured
  • Cytomegalovirus (immunology)
  • Cytomegalovirus Infections (immunology)
  • Epstein-Barr Virus Infections (immunology)
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunoglobulins (immunology)
  • Killer Cells, Natural (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: